U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Name Type Language
FONTOLIZUMAB
INN   USAN  
INN   USAN  
Official Name English
HUZAF
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERFERON .GAMMA.) (HUMAN-MOUSE MONOCLONAL HUZAF .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUZAF LIGHT CHAIN, DIMER
Common Name English
FONTOLIZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERFERON .GAMMA.) (HUMAN-MOUSE MONOCLONAL HUZAF .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HUZAF LIGHT CHAIN, DIMER
Common Name English
Fontolizumab [WHO-DD]
Common Name English
fontolizumab [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
Code System Code Type Description
WIKIPEDIA
Fontolizumab
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
PRIMARY
INN
8264
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
PRIMARY
NCI_THESAURUS
C87765
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
PRIMARY
FDA UNII
6J92H2439Z
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
PRIMARY
DRUG BANK
DB05111
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
PRIMARY
USAN
NN-71
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
PRIMARY
CAS
326859-36-3
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108459
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
PRIMARY
SMS_ID
300000021921
Created by admin on Mon Mar 31 20:35:13 GMT 2025 , Edited by admin on Mon Mar 31 20:35:13 GMT 2025
PRIMARY
ACTIVE MOIETY
FONTOLIZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966